CISH inactivated TIL(Intima Bioscience)

N/A

Report date: 2026/04/17 10:36:05

Base Information

Drug NameCISH inactivated TIL(Intima Bioscience)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsAdenocarcinoma of Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIntima Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIntima Bioscience Inc

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsAdenocarcinoma of Lung

Other Information

ATC CodeN/A